Assembly Biosciences, Inc. (ASMB)

Assembly Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	24.01	38.34	19.84	52.42	45.63	59.44
Short-Term Investments	50.97	73.74	110.41	39.19	101	156.97
Cash & Short-Term Investments	74.98	112.08	130.25	91.61	146.63	216.41
Cash Growth	-31.35%	-13.95%	42.18%	-37.52%	-32.25%	-21.03%
Accounts Receivable	-	-	0.04	0.94	0.34	1.23
Other Receivables	0.3	0.4	0.3	0.3	-	-
Receivables	0.3	0.4	0.34	1.24	0.34	1.23
Prepaid Expenses	2.19	3.02	3.2	4.11	7.24	6.85
Total Current Assets	77.47	115.5	133.79	96.97	154.2	224.49
Property, Plant & Equipment	3	3.35	2.72	3.94	7.18	10.73
Long-Term Investments	-	-	-	-	27.97	-
Goodwill	-	-	-	-	-	12.64
Other Intangible Assets	-	-	-	-	-	29
Long-Term Deferred Charges	-	-	-	0.2	0.2	0.8
Other Long-Term Assets	0.31	0.31	0.31	0.69	1.5	5.59
Total Assets	80.78	119.17	136.82	101.79	191.06	283.25
Accounts Payable	0.74	0.59	0.46	2.49	2.66	4.6
Accrued Expenses	5.1	9.14	6.63	9.84	10.26	12.27
Current Portion of Leases	0.53	0.46	1.22	3.36	3.15	3.4
Current Unearned Revenue	40.92	37.62	30.92	-	-	-
Other Current Liabilities	-	-	-	0.6	-	4.16
Total Current Liabilities	47.29	47.8	39.23	16.3	16.07	24.43
Long-Term Leases	2.35	2.63	1.12	0.1	3.33	6.73
Long-Term Unearned Revenue	13.04	35.38	55.38	2.73	2.73	8.99
Long-Term Deferred Tax Liabilities	-	-	-	-	-	2.53
Total Liabilities	62.68	85.81	95.73	19.13	22.13	42.68
Common Stock	0.01	0.01	0.01	0	0.05	0.03
Additional Paid-In Capital	863.31	859.49	826.92	807.98	800.73	742.39
Retained Earnings	-844.94	-825.93	-785.75	-724.52	-631.43	-501.57
Comprehensive Income & Other	-0.28	-0.21	-0.08	-0.8	-0.42	-0.27
Shareholders' Equity	18.1	33.36	41.1	82.66	168.93	240.58
Total Liabilities & Equity	80.78	119.17	136.82	101.79	191.06	283.25
Total Debt	2.88	3.09	2.34	3.47	6.48	10.13
Net Cash (Debt)	72.1	108.99	127.91	88.15	168.12	206.28
Net Cash Growth	-32.92%	-14.79%	45.11%	-47.57%	-18.50%	-21.20%
Net Cash Per Share	10.28	18.15	27.94	21.85	46.61	69.87
Filing Date Shares Outstanding	7.67	7.5	5.48	4.33	4.01	3.19
Total Common Shares Outstanding	7.67	7.46	5.48	4.07	4.01	2.84
Working Capital	30.18	67.7	94.56	80.67	138.13	200.06
Book Value Per Share	2.36	4.47	7.50	20.29	42.13	84.84
Tangible Book Value	18.1	33.36	41.1	82.66	168.93	198.94
Tangible Book Value Per Share	2.36	4.47	7.50	20.29	42.13	70.16
Machinery	-	-	-	0.8	0.72	0.95
Leasehold Improvements	-	-	-	1.63	1.63	2.49

Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q